| Extend product lifecycles through reformulation to keep market share |
openPR (press release)This must-attend event will once again lead the way in examining the latest developments in nanomedicine and featuring fresh presentations from companies including GlaxoSmithKline, Lundbeck, Merck Serono and Genzyme. Controlled Release will allow ...
|
| 16 new jobs at Waldner as turnover set for €8m |
Herald.ieWaldner Ireland supply Genzyme, ISPEN, University College Cork, Dublin City University and Pfizer have installed a €3m lab with the State and Agricultural Laboratories. Noel Hodgins, managing director of Waldner Ireland, said Ireland is now being ...
|
| Dyslipidemias in Children |
Pediatric SuperSiteDr. Linton has disclosed the following relevant financial relationships: Merck, research consultant; Pfizer, research; ISIS/Genzyme, research; Kowa, consultant. Dr. Fazio has disclosed the following relevant financial relationships: Merck, Takeda, ...
|
| Sanofi cutting Genzyme research jobs |
Boston GlobeBy Robert Weisman French drug maker Sanofi SA, which last year bought Cambridge biotechnology company Genzyme Corp., said it was eliminating an unspecified number of overlapping jobs in Genzyme's research and development operations.
|
| Genzyme Shakeup Will Keep Employee Count Level |
Worcester Business JournalBy Brandon Butler Sanofi, the new owner of Cambridge research company Genzyme, which has major manufacturing operations in Framingham, today announced plans to lay off some of its employees. But, as part of the reorganization, positions will be added ...
|
| Genzyme hit with layoffs as Sanofi integration continues |
Boston Business JournalGenzyme Corp.'s research and development operations in Massachusetts have been cut by an unspecified number of positions, according to parent company Sanofi (NYSE: SNY). The positions have been eliminated to avoid redundancy between Sanofi and Genzyme ...
|
| STATEMENT: Sanofi restructures R&D in new Boston hub |
FierceBiotechThe company has continued to grow through external partnerships and business development, most recently through the acquisition of Genzyme Corporation last year. As part of the integration process between Sanofi and Genzyme, R&D activities were ...
|
